28th Annual North American Cystic Fibrosis Conference

S03: NT: Outcome Measures With a Focus on Young Children With CF

Oct 9, 2014 2:00pm ‐ Oct 9, 2014 3:50pm

Standard: $49.99


This session will provide insight into outcomes for assessment of early lung disease in cystic fibrosis. It will highlight those outcomes with greatest potential for use in early intervention trials, those best for detecting early disease and those suited to monitoring progress. As knowledge about the nature of early lung disease accumulates, this information is crucial if we are to intervene to prevent the early onset and progression of lung disease in CF.


You must be logged in and own this session in order to post comments.